Stay updated on Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also applies a formatting change to the Intervention/Treatment label and adds a Revision: v3.6.0 note, replacing the prior Intervention / Treatment label and Revision: v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T12:17:57.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision bumped from v3.5.4 to v3.5.5, signaling a new page version within ClinicalTrials.gov. The change represents a backend or formatting update rather than a modification to the study content or eligibility details.
    Difference
    0.0%
    Check dated 2026-06-05T08:39:06.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.4, signaling a newer version of the page. This update does not change the study details or the information presented to users.
    Difference
    0.0%
    Check dated 2026-05-14T23:03:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, indicating a minor page revision.
    Difference
    0.0%
    Check dated 2026-04-30T16:40:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.2; the prior revision v3.5.0 was removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:34:35.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T20:16:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Gastric Cancer Clinical Trial page.